{
  "docId": "019de071-b74f-770c-80cd-22f6f746fca1",
  "docSlug": "da6e8db4dad70fc7ff4e589a15b2ab41",
  "documentTitle": "BioNTech | Results Presentation Deck | 40 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 40,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "key_messages",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Slide 14 from a BioNTech presentation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-b74f-770c-80cd-22f6f746fca1/14",
  "deckHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1",
  "deckJsonHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1.json",
  "deckAnchorHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.08,
        "y": 0.335
      },
      "kind": "list",
      "text": "Clinical Trials Evaluating Booster Dose For Immunogenicity, Reactogenicity and Vaccine Efficacy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35462f84-0f38-40fe-a4df-4ef7fbc14a54",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.08,
        "y": 0.715
      },
      "kind": "list",
      "text": "Trials Evaluating Variant-Encoding Vaccines Support Flexible Platform Approach to Product Adaptation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc2992c6-7619-440b-963b-2149073fe9e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.51,
        "y": 0.65
      },
      "kind": "other",
      "text": "3: Beta Variant-Encoding Vaccine: 3rd dose or naïve, Safety & immunogenicity trial, N=~300 (Ph 3); N=~300 (naïve), Data in Q1 2022",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33e406b1-9b29-40c8-bc99-d97f7e177dcc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.51,
        "y": 0.3
      },
      "kind": "other",
      "text": "1: BNT162b2: 3rd dose, Safety & immunogenicity trial, N=23 (Ph 1); N=~300 (Ph 2/3), First data published",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35eb4ffd-41e7-4a60-9114-08c75974090d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.73,
        "y": 0.3
      },
      "kind": "other",
      "text": "2: BNT162b2: 3rd Dose, Safety & Vaccine Efficacy trial, N=~10,000 (Ph 3), Data in Q4 2021",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46a4a7e2-506d-40bf-a86f-d4c27f73cb30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.73,
        "y": 0.65
      },
      "kind": "other",
      "text": "4: Multivalent Delta + Alpha or Delta or Alpha Variant-Encoding Vaccines as 3rd dose or in naïve subjects, Safety & immunogenicity trial, N=~600; N=~300 (naïve), Data in Q4 2021",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d025713a-343a-4279-a1f4-25d455e795a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.04,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "To date, no clinical evidence to advocate need to change vaccine to variant-specific version of vaccine. Platform approach preemptively prepares for the need, should it arise with a more severe/transmissible variant of concern.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "071c19e6-9bd5-4953-a334-1ccc2c8f9380",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Clinical data supports a booster dose of the vaccine in adults or high risk populations to augment vaccine protection over time",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47440bdb-7d4e-42e1-b8a5-9502d3cfcf77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Clinical Strategy Supports Boosters and Platform Approach to Variants",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c89d6bf-34d1-4071-a8e7-824f69477ae4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 11,
      "beatId": "3ef0a596-8c25-4f98-9ce3-ac572ab324b0",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation provides key messages and takeaways on COVID-19 vaccine reach and therapeutic modalities",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "e3928016-4f85-43ef-b051-6dae022547eb",
      "evidence": "The presentation provides a clear logic chain of performance and pipeline growth",
      "position": 0,
      "objective": "To demonstrate BioNTech's strong performance and pipeline expansion",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}